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Several years ago our laboratory described procedures for eliciting and de- 
tecting a  graft-vs.-host reaction in tissue cultures (1,  2).  In direct analogy to 
the in vivo system, we demonstrated the enlargement of explanted fragments 
of neonatal F1 spleen can be obtained when such fragments are  exposed  to 
immunocompetent adult parental lymphoid cells.  Such in vitro splenomegaly 
could be observed in 3-4 days, and was accompanied by many of the histo- 
logical changes typical of in vivo graft-vs.-host disease (2). 
Of all the methods now established as in vitro correlates of cellular immunity, 
the graft-vs.-host reaction seemed to represent perhaps the most accurate re- 
flection of an in vivo cellular immune reaction, yet its potential utility appeared 
to us to have been almost overlooked (cf. 3-6). Perhaps in part this has been 
due to the slightly less conventional methods of tissue culture used, in part to 
the absence of ready quantitation of the response, and in part because of the 
developmental orientation of  the  studies  in  which  this  technique has  been 
employed (cf. 7-12). Because of the increasing importance of in vitro methods 
and  because  of  the  specific  interest  in  the  graft-vs.-host  reaction  in  trans- 
plantation studies, we decided to refine the previous procedures for obtaining 
an in vitro graft-vs.-host reaction, to establish the quantitative potential of the 
technique, and to apply the new methodology in studying a number of experi- 
mental questions. 
Materials  and Methods 
General Methodology.--The experimental procedure is  summarized in  Fig.  1.  A  double 
culture well system (cf. 7) employing a millipore filter assembly and a plastic organ cultures 
dish is used. Known numbers of test cells  (parental) are placed in one of the wells, while an 
equivalent number of control cells (F1) is added to the other one. Neonatal (1-2-day old) F1 
animals serve as a  source of spleen tissue explants, two fragments, matched for size,  being 
used for each culture dish; one fragment is placed with the test cells while the other is cul- 
tured with control cells.  After an appropriate incubation period, tritiated leucine is added 
to the culture medium and the cultures are further incubated for 12-24  h. The amount of 
incorporation into each of the fragments is then measured, and the ratio of incorporation of 
the fragment cultured with test cells to incorporation of the fragment cultured with control 
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FIG.  1. Schematic diagram of experimental procedure. 
cells is determined. In direct analogy to the in vivo system, this ratio is defined as the Spleen 
Index. An index of 1.2 is considered positive. 
Cell Suspcnsitms.--C58BL/6  and BDF1  (C57BL/6 X  DBA/2) mice were obtained from 
our own colony or from ARS Sprague Dawley (Madison). Adult organs were removed, placed 
in saline solution containing 10% fetal calf serum (Grand Island Biological Co., Grand Island, 
N. Y.), and prepared as cell suspensions by gentle teasing. Cell counts were obtained by use 
of a Nuclear Chicago particle size analyzer (Coulter principle) (Nuclear-Chicago Corp., Des 
Plaines, Ill.) using size discrimination or cell lysis to obtain accurate counts of nucleated cells. 
Dilutions were then made to permit 5/zl to contain the appropriate number of cells to be 
added to each filter well. 
Tissue  Fragments.--1-2-day  old  BDF1  spleens were  dissected  in saline.  10-20  of  these 
spleens were placed on a  chopping plate of a  McIlwain tissue chopper and cut into 0.8-mm 
slices perpendicular  to  the long axis.  Fragments were  transferred  to saline,  then visually 
matched as pairs for explantation into individual organ culture dishes. 
Millipore  Filter Assembly.--Sheets  of  0.030 inch (ca. 0.8 ram)  thick  plexiglas (Cadillac 
Plastics and Chemical Co., Detroit, Mich.) were cut into strips measuring 25 X  6 mm. Two 
3-mm holes were drilled into each strip using a drill press and mold to facilitate handling. One 
side of the strip was marked to facilitate subsequent orientation. A small rectangle of ultra- 
thin milUpore  (THWP)  filter material was glued  to  the  plexiglas  assembly using CD125 1508  GRAFT-VS.-HOST  REACTION  IN  TISSUE  CULTURE 
(Cadillac) cement. The complete assembly was sterilized in 70% alcohol and rinsed in saline 
before use. 
Tissue Culture.--The  culture medium consisted of  Eagle's basal medium supplemented 
with  10% horse serum  (Grand Island), 5% chick embryo extract  (9-day embryos), genta- 
mycin (50 ~g/ml), and mycostatin (50/~g/ml).  1:1 ml of medium was placed into no. 3037 
Falcon organ culture dishes (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.); medium was 
normally not changed during the experiment. Cultures were incubated in a moist chamber of 
95% oxygen and 5% CO2 at 37°C. 
Experimental  Procedures.--The  falter  wells were individually aspirated to remove excess 
saline after which 5 #1 of test (parental) cells were added to one well, while 5/zl  of control 
(F1) ceils were added to the other well. The assembly was then placed in a culture dish con- 
taining medium. After all assemblies were filled with cells, spleen fragments were prepared as 
described above and two fragments were matched for size and placed in the wells.  After  an 
appropriate period of incubation (see results) 0.4/~Ci of tritiated leucine were added  to the 
medium of each dish and after an additional period of  12-24 h  the spleen fragments  were 
removed individually, rinsed in saline, and placed in scintillation vials each containing 0.05 
ml of water. 0.5 ml of  tissue  solubillzer (TS-1, Research  Products Int.) was  added  to  each 
vial; vials were allowed to stand for a minimum of 24 h at room temperature before the  addi- 
tion of 5 ml tohiene-PPO-POPOP scintillation fluid for counting. Since spleen fragments were 
initially matched for size and maintained under identical culture conditions except for  the 
nature of the cells added  (i.e.,  parental vs. F1)  the spleen index could be directly  calculated 
as  the ratio of counts of experimental/control for each culture dish. 
Chemicals.--Amantadine  hydrochloride was  obtained as  a  gift from  E.  I.  Du  Pont De 
Nemours and Co.  (Wilmington, Del.), dissolved in standard tissue culture medium, and ster- 
ilized  by  millipore  filtration.  Mitomycin  C  (Nutritional Biochemical  Corporation,  Cleve- 
land, Ohio) was prepared as a stock solution of 0.5 mg/ml. For mitomycin C treatment of cells 
1 ml of a  cell suspension containing between 5 X  107 and 1 X  10 s cells was incubated with 
0.05 ml of mitomycin C stock solution for 20 min after which cells were washed three times 
before explantation. To obtain "cortisone-resistant thymus cells," mice were injected intra- 
muscularly with 2.5 mg hydrocortisone acetate 3 days before utilization. 
X  irradiation.--Irradiation  was performed on a  GE Maxitron 300 X-ray machine  (Gen- 
eral Electric Co., Pleasanton, Callf.), operating at 20 mA, 300 kVp with 0.5-ram Cu and 1.0- 
mm A1, at a dose rate of approximately 70 R/min, as measured in air by a Victoreen dosime- 
ter (Victoreen Instrument Div., Cleveland, Ohio). 
Additional  Culture  Information.--Several  simplifications  have  been  found  acceptable 
although not employed in the course of the present study. 
Medium:  A mixture of 5% fetal calf serum and 5% horse serum eliminates the need for 
chick embryo extract. 
Gas mixture:  Mixtures containing 5% CO2  and 50% or more oxygen are adequate.  In 
general, smaller fragments require less oxygen. 
Assay  of  radioactivity:  Pooling  of  fragments  (experimental  vs.  control)  from  several 
cultures  vastly simplifies assay procedure  without  appreciably  affecting statistical signifi- 
cance  (cf. Table I). In this case, however, individual culture viability can only be assessed 
visually before assay. Other labeled amino acids can be substituted for leucine. 
Culture dishes andfilter  assembly:  A standard 35-mm culture dish can be used by inserting 
a  glass ring to support the filter mount. A  multiple filter assembly containing 3-5 pairs of 
wells can be constructed for use in such dishes. Care must be taken, however, to maintain 
fluid level at the correct height to assure culture viability and prevent excessive flattening of 
the  spleen  explants.  Somewhat  thicker  (0.040  inch)  plexiglass  facilitates maintenance  of 
fluid levels in multiple filter assemblies. ROBERT  AUERBACH  AND  ~f.  R.  SHALABY  1509 
RESULTS 
Validation of the Methodology.--As a  standard  effector cell population  we 
employed  106  spleen  cells,  and  splenomegaly induced  in  neonatal  explants 
was assessed by incorporation of trifiated leucine during the 4th day of cul- 
ture. The detailed results of 16 consecutive experiments involving  148 pairs 
of explants are shown in Table I.  Confidence limits for selected numbers of 
cultures/experiment have been included in order to provide a  frame of refer- 
ence for the  remainder of the  experimental  results  presented  in  our  study. 
Based on these results, an index of 1.2 or greater was accepted as indicating a 
positive graft-vs.-host reaction. 
Immunocompetence of Lymphoid Cell Populations: Time-Dose Studies.--In 
order to provide a basis for comparison of various cell populations, the number 
of cells tested and the time interval during which labeled leucine was available 
to the cultures were varied. The results of a single experiment with adult spleen 
cells are shown in Table II. This and other experiments indicate that spleno- 
megaly occurs earlier in cultures containing a  higher number of immunocom- 
petent cells and  that maximal  enlargement of spleen explants fails to occur 
when the number of immunocompetent cells becomes restricted. 
Similar time-dose studies were carried out with thymus cells, with cortisone- 
resistant thymus cells, with inguinal lymph node cells, with mesenteric lymph 
node cells,  with thoracic duct lymphocytes, and with bone marrow cells.  The 
results of these studies are shown in Tables III-VIII. 
Immunosuppression: Effects of  Amantadine Hydrochloride, Mitomycin  C 
and X-rays.--Because of the apparent selectivity by which amantadine affects 
lymphoid cells (13)  we decided to examine the effect of this drug on immuno- 
competence as  expressed in  the  in  vitro  graft-vs.-host  reaction.  Concentra- 
tions of 100 #g or less did not influence the amount of incorporation of leucine 
into  control  cultures  and  were  therefore not  considered to  have  significant 
toxic effects. The results, shown in Table IX, indicate that 50 #g/ml is partially 
inhibitory while concentrations of 75  ~g/ml or higher completely inhibit the 
graft-vs.-host  reaction  in  vitro.  It  should  be  noted,  moreover,  that  since 
6 X  104 spleen cells normally cause a measurable response when assayed after 
3 days of incubation  (cf. Table II) whereas l0  s cells failed to do so in 75 ~g 
amantadine-containing media,  immunosuppression must  have been in excess 
of 95 % in these cultures. We did not, however, test other cell concentrations. 
Because of the known inhibitory effects of mitomycin C in the mixed lympho- 
cyte reaction (14), we studied the effect of pretreatment of adult spleen cells 
with mitomycin C on their subsequent ability to induce a graft-vs.-host reaction 
in vitro. The results, shown in Table X, indicate that mitomycin C is an effective 
inhibitor of immunocompetent spleen cells as measured in our system. 
To examine the degree of radiation sensitivity of immunocompetent spleen 
cells,  adult  donor animals were given total body irradiation  24 h  before re- 1510  GRAFT-VS.-HOST  REACTION IN  TISSUE CULTURE 
TABLE I 
Ability of 106  C57BL/6  Spleen  Cdls  to Induce  Splenomegaly in Explanted  Neonatal BDF1 
Spleen Fragments as Measured by Incorporation of [3H]leucine on the 4th Day of 
Culture (16 Consecutive Experiments) 
No. of  Individual spleen indexes  Mean  SE  SD  Exp.  cult. 
1  16  1.25;  1.58;  1.25;  1.71;  1.34;  1.49;  1.40;  1.49  .08  .30 
1.07;  1.50;  1.30;  1.49;  1.34;  1.42;  1.40; 
1.89;  2.35 
2  6  1.40;  1.07;  0.93;  1.37;  1.43;  1.50  1.28  .09  .23 
3  8  1.25;  1.48;  1.33;  1.86;  1.52;  1.35;  1.98;  1.55  .09  .26 
1.63 
4  20  1.21;  1.32;  1.53;  1.75;  1.37;  1.24;  1.81;  1.33  .06  .27 
.92;  1.54;  1.34;  .85;  1.25;  1.59;  .94; 
1.28;  1.07;  1.49;  1.69;  1.30;  1.17 
5  4  1.47;  1.42;  1.64;  0.67*  1.30  .25  .43 
6  8  2.05;  1.31;  1.07;  1.48;  1.59;  2.15;  1.64;  1.64  .13  .36 
1.84 
7  17  1.73;  1.61;  0.99;  1.70;  1.68;  1.52;  0.75;  1.59  .10  .40 
1.54;  1.67;  1.54;  1.28; 2.28;  1.40;  1.75; 
1.74;  1.35; 2.44 
8  10  1.22;  2.02;  1.91;  1.13;  1.82;  1.82;  1.31;  1.56  .11  .34 
1.78;  1.24;  132 
9  8  1.16;  1.51;  0.75;  1.42;  1.53;  1.42;  1.54;  1.31  .10  .28 
1.12 
10  10  1.60;  1.36;  1.68;  0.99;  1.64;  1.22;  1.41;  1.51  .15  .46 
1.70;  2,57; 0.97 
11  8  1,47;  1.15;  1.23;  1.02;  1.18;  1.88;  1.48;  1.34  .10  .27 
1.27 
12  5  1.44;  1.27;  1.39;  1.18;  1.36  1.33  .04  .10 
13  8  1.50;  1.18;  1.65;  2.19;  1.35;  1.76;  1.86;  1,64  .11  .31 
1.61 
14  4  1.85;  2.18;  1.44;  1.24  1,68  .21  .42 
15  8  1.53;  0.97;  1.47;  1.27;  0.93;  1.71;  1.57;  1,32  .10  ,29 
1.11 
16  8  1.79;  1.59;  1.78;  1.50;  1.47;  1.18;  1.92;  1,55  .10  .28 
1.17 
* probably reversed 
All experiments: 148 cultures  1.47  .03  .33 
Mean of means  1.46  .04  .14 
Confidence limits  5 cultures  9 cultures  16 cultures 
50%  O. 10  0.07  0.05 
80%  O~ 19  O. 14  O. 11 
90%  0.24  0.18  0.14 
95%  0.29  0.22  0.16 ROBERT  AUERBACH  AND  M.  R.  SIIALABY  1511 
TABLE  II 
Ability of C57BL/6 Spleen Cells to Induce Splenomegaly in Explanted BDF1 Neonatal 
Spleen Fragments 
Time of labeling (h  Spleen index 
after incubation)  1.0 X 106*  2.5 X 105"  6.0 X 104*  1.5 X 104* 
24-36  [  1.09  1.04  0.93  0.93 
36-48  1.24  ]  1.05  0.96  1.13 
48-60  1.45  1.34  1  0.97  1.04 
60-72  1.60~  1.88  1.20  [  1.07 
72-84  1.29  1.36  1.34  ]  1.17 
Each index represents six cultures/group.  1.2 is considered positive. 
* Number of cells. 
~: Five cultures. 
TABLE  III 
Ability of C57BL/6  Thymus Cells to Induce  Splenomegaty in Exptanted  BDF1 
Neonatal Spleen Fragments 
Time of labeling (h after 
incubation 
Spleen index 







0.96  1.01  0.95 
1.01  1.00  0.89 
1.17  1.07  1.23~ 
1.34  [  1.02  1.05 
1.45§  1.33~  1.00, 
1.93  1.48  1.08 
Each index represents six cultures/group. 
* Number of cells. 
Five cultures. 
§ Four cultures. 
TABLE  IV 
Ability  of Thymus  Cdls from  Cortisone-Treated C57BL/6  Mice to Induce  Splenomegaly in 
Explanted BDF1 Neonatal Spleen Fragments 
Time of labeling (h after 
incubation) 
Spleen index 
1.0 X  106*  2.5 X  105*  6.0 X  104. 
24-36  i. 05 
36-48  1.35 
48-60  1.44 
60-72  1.46 
72-84  1.77 
1.00  0.97 
1.08  1.12 
1.32  1.08 
1.65  1.00 
1.58  1.19 
Each index represents five cultures/group. 
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TABLE  V 
Ability of C57BL/6 Inguinal Lymph Node Cells to Induce  Splenomegaly in Explanted BDF1 
Neonatal Spleen Fragments 
Time of labeling (h  Spleen index 







1.14  1.11  1.13  0.93 
1.15  1.14  1.03  1.15 
1.17  1.02  1.09  1.06 
[  1.10  1.16  1.10  1.21  t 
1.42  1.23  1.24  [.  1 101 
1.35  1.25  1.18  1.18 
Each index represents 10 cultures/group, two experiments. 
* Number of cells. 
TABLE  VI 
Ability of C57BL/6 Mesenteric Lymph Node Cdls to Induce Splenomegaly in Explanted BDF1 
Neonatal Spleen Fragments 
(Time of labeling(h  Spleen index 
after incubation)  1.0 X 106.  2.5 ~( 105*  6.0 X 104*  1.5 X 104* 
24-36  1.12  1.11  1.06  1.12 
36-48  1.04  1.16  1.17  0.99 
48-50  1.37  1.43  I  1.13  0.98 
60-72  1.54  1.18  1.21  [  1.07 
72-84  1.17  1.43  1.16  1.23[ 
k 
Each index represents six cultures/group. 
* Number of cells. 
TABLE  VII 
Ability of C57BL/6  Thoracic Duct Lymphocytes to Induce  Splenomegaly in Exflanted BDF1 
Neonatal Spleen Fragments 
Time of labeling (h after 
incubation) 
Spleen index 
1  X  106*  2.5  X  l0 b*  6.0  ~(  104. 
24-36  1.34~  1.29§  1.275 
36--48  1.41:~  1.34[[  1.181[ 
48-50  2.035  1.261[  1.2011 
60-72  1.99~  1. 651[  1.48[[ 
72-84  1. 6011  1.261[ 
* Number  of  ceils.  F1  control  cells  used  in  60%  of  cultures  only.  Presence  of  control 
thoracic duct lymphocytes did not influence spleen index. 
:~ 5 cultures. 
§ 3 cultures. 
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TABLE VIII 
Ability of C57BL/6 Bone Marrow Cells to Induce Splenomegaly in Explanted BDFI Neonatal 
Spleen Fragments 
Time of labeling  (h after 
incubation) 
Spleen  index 
8.0 X  106*  2.0 X  106*  5.0 X  105" 
3648  0.95  0.96  1.16 
48-60  0.92  1.07  1.13 
60-72  1.03  0.97  1.16 
72-84  1.15  0.89  1.06 
84-96  N.V.~  0.96  1.15 
* Number of cells. 
Control cultures show inhibition  of incorporation  of [SH]leucine. 
TABLE IX 
Effect  of Amantadine  Hydrochloride on  the Ability of 10 6  C57BL/6  Spleen  Cells to Induce 
Splenomegaly in Explanted BDF1 Neonatal Spleen Fragments (Results of 
Three Experiments) 
Concentration of  Number of cultures  Spleen index  4- SE 
amantadine HCI 
Control  29  1.56  -4-0.07 
10  15  1.63  d=0.11 
25  15  1.68  :t:0.12 
50  21  1.21  d:0.05 
75  15  1.00  :t:0.04 
100  8  0.91  :t:0.08 
150  7  1.05*  :k0.05 
Cells Labeled from 72 to 96 h. 
* Reduced  incorporation  of  [~H]leucine in control  cultures  indicates  general  toxicity at 
this concentration. 
TABLE X 
Effevt of Mitomycin  C on the Ability of C57BL/6 Spleen Cells to Induve Splenomegaly in BDFI 
Neonatal Spleen Explants 
Number of cells 
Spleen index 
+  Mitomycin C  Control 
1.0  X  106  1.08  1.41 
5.0  X  105  1.12  1.34 
2.5  X  105  1.16  1.31 
Each index represents eight cultures/group.  Cells labeled from 48 to 72 h. 
moval of their spleens.  The results are  shown in Table XI. Again, referral to 
Table  II provides the necessary information for calculating the effective im- 
munosuppression  achieved by  various  doses  of X-irradiation.  In  addition  to 
the  experiments shown in Table XI,  we examined  the  effect of various doses 1514  GRAFT-VS.-]~IOST REACTION  IN  TISSUE  CULTURE 
TABLE XI 
Effect of X-Irradiation  on the Subsequent Ability  of C57BL/6 Spteen Cells to Induce 
Splenomegaly in Neonatal BDF1 Spleen ExpIants 
Dose of X-ray 
Spleen index 
1 X  106*  5 X  105"  2.5 X  10s* 
0 R  1.47  1.45 
250 R  1.31  1.09 
500 R  0.90  1.04 
750 R  1.16 
1,000R  0.88 
1.26 
1.08 
Each index represents 10 cultures/group. Cells labeled from 48 to 72 h. 
* Number of ceils. 
of X-rays on spleen cell suspensions just before their being placed in  culture 
wells; the results were comparable to those achieved with irradiation in vivo. 
Effect  of Preimmunization  on Spleen Effector Cells.--To  study the  effect of 
preimmunization  in  our  system,  108  adult  DBA  spleen  cells  were  injected 
intraperitoneally into  adult  C57BL/6 mice 5-7 days before spleen cells from 
such animals were used in the in vitro test system. The results shown in Table 
XII indicate  that while preimmunization  results in  increased cytotoxicity at 
high  cell densities  (106 cells/filter well)  it  does not  increase  the  efficiency of 
low densities of spleen cells to induce splenomegaly in vitro. 
We next examined the effect of preimmunization on radiation sensitivity of 
the effector cell  (7). Preimmunized or control animals were given 500 R  24 h 
before their  spleen  cells were used for in vitro assessment of immunocompe- 
tence  (cf. Table XI). The results are shown in Table XIII, and indicate that 
preimmunization does have a  protective effect on radiation  sensitivity of the 
immunocompetent spleen cell population. 
It could be argued,  however, that preimmunization enhanced  the response 
to non-H-2 antigens, and it was this response that was being measured in the 
experiments involving preimmunization of C57BL/6 animals with DBA cells. 
We  therefore  repeated  the  experimental  procedures,  employing  C57BL/10 
animals preimmunized with spleen cells from C57BL/10 D2 mice. The results 
are shown in Table XIV, and indicate that the protective effect of preimmuni- 
zation  on  radiation  sensitivity  of  immunocompetent  cells  can  be  seen  in  a 
congenic  system in  which  only the  major histocompatibility complex is  dis- 
similar. 
Graft-vs.-Host  Reaction  across  Weak  Non-H-2  Barriers.--To  examine  the 
sensitivity of the in vitro graft-vs.-host reaction to detect weak histocompati- 
bility  differences the strain  combination of BALB/C  and DBA/2  was used. 
For  these  experiments neonatal  spleen  explants  were  matched  in  groups  of 
three  fragments to permit  the  same control  cultures  to be used  in  assessing 
immunocompetence  of  cells  from both  parental  sources.  At  the  same  time, ROBERT  AUERBACH AND  ~£.  R.  SHALABY  1515 
TABLE XII 
Effect of Preimmunization with DBA  Cells on the Ability of C57BL/6 Spleen  Cells to Evoke a 
Graft-vs.-Host  Reaction  against  BDF1 Neonatal  Spleen  Explants 
Number of cells  Time of labeling 
Spleen index 
Preimmunized  Normal 
k 
1  X  106  24-48  1.03  ,1.25 
48-72  0.81  1.37 
2.5  X  105  24-48  1.05  1.04 
48-72  1.37  1.38 
6.0  X  104  24-48  1.18  1.08 
48-72  1.20  1.21 
3.0  X  104  48-72  1.05  0.98 
72-96  1.11  1.04 
1.5  X  104  24-48  1.05  0.97 
48-72  1.11"  1.08* 
72-96  1.15  1.07 
7.5  X  103  48-72  0.93  1.09 
72-96  0.84  1.06 
Each index represents six cultures/group. 
* 12 cultures. 
TABLE XIII 
Effect of Preimmunization against DBA  on the Ability of Irradiated  C57BL/6 Spleen  Cells to 
Induce Splenomegaly in Explanted  Neonatal BDF1 Spleen Fragments 
Spleen index 
1 X  106*  5 X  10 b*  2.5  X  10s* 
Preimmunized +  500 R X-ray  1.48  1.34  1.32 
500 R X-ray only  1.03  0.90 
Each index represents 10 cultures/group. Cells labeled from 48 to 72 h. 
* Number of cells. 
TABLE XIV 
Effect  of Preimmunizatlon against BIO. D2 on the Ability of Irradiated  C57B/10 Spleen  Cells 
to Induce Splenomegaly in Explanted  Neonatal BDF1 Spleen Fragments 
Treatment 
Spleen index 
1 X  10  s*  5  X  105"  2.5  X  10 s* 
Preimmunized +  500 R X-ray  1.35  1.29 
500 R X-ray only  1.12  1.12 
Untreated  1.30~  1.49:~ 
1.23 
Each index represents 18 cultures/group. Cells labeled from 48 to 72 h. 
* Number of cells. 
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the cell suspensions were tested for their ability to induce a graft-vs.-host reac- 
tion in vivo. The results are shown in Table XV, and indicate that a weak but 
clearly detectable response could be obtained in vitro. 
TABLE XV 
Ability of Spleen Cells from DBA/2 or BA LB/C Mice to Induce a Graft-vs,-Host  Reaction 
against FI (BALB/C  X  DBA) In Vivo or In Vitro 
Cells tested  No. of animals  Mean  spleen  index 
In vivo* 
In vitro$ 
BALB/C  X  DBA/2  9  (1.00) 
BALB/C  11  0.87 
DBA/2  11  0.96 
No. of cultures 
BALB/C  17  1.21 
DBA/2  17  1.20 
* 5  X  106 cells injected into 2-3-day old mice, assayed 9  or  11  days later  (two experi- 
ments). 
106  cells/culture, three-way match, each set including one control culture of BALB/ 
C X  DBA cells; labeled from 48 to 72 or 72 to 96 h  (two experiments). 
DISCUSSION 
A primary purpose of our report has been to validate the in vitro graft-vs.- 
host reaction  as an experimental system. We feel that  this has been accom- 
plished. We have demonstrated that a  graft-vs.-host reaction can be induced 
by appropriate numbers of spleen, lymph node, thoracic duct, or thymus cells, 
that  the radiation  sensitivity of immunocompetent cells measured in vitro is 
similar to that seen in vivo, that cortisone treatment leaves a highly competent 
thymus cell population, and that preimmunization does not appear to change 
the number of effector cells active across strong H-2 barriers. 
A number of findings of our study, however, require further discussion. Our 
observation that bone marrow cells do not  cause a  graft-vs.-host reaction in 
vitro may have several possible explanations.  Of these the simplest one is to 
ascribe their failure to technical reasons. If the number of immunocompetent 
cells in the bone marrow is lower than it is in the untreated  thymus  (cf.  15) 
then  the  concentration  of bone  marrow  cells  required  to  induce  a  graft-vs.- 
host reaction in vitro is too great to permit long-term viability of the cultures. 
Indeed we found that at a concentration of 8 X  10  6 cells/culture viability was 
only marginal by the end of the 3rd day of culture. The use of cell separation 
techniques  to  obtain  a  higher  yield  of  presumed  immunocompetent  bone 
marrow cells should permit test of this explanation. On the other hand, it may 
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could take place in vivo, but may simply not occur in vitro Or be achieved 
too slowly to be recognized during  the 3-4-day culture period; In fact, em- 
bryonic liver cells appear to follow this pattern (8, 9). 
Our observation that amantadine inhibits the graft-vs.-host reaction in vitro 
becomes particularly interesting in the light of the observation by Mardiney 
and  Bredt  (13)  that  amantadine  interferes with  immunological  recognition 
but not with the response of lymphocytes to phytohemagglutinin. Taken to- 
gether with the observation that mitomycin C  inhibits the graft-vs.-host re- 
action it suggests to us that our in vitro system may provide a most sensitive 
tool for distinguishing between general and more specific immunosuppressive 
effects. 
To us there has long been some ambiguity concerning the effect of preim- 
munization on effector cells in the graft-vs.-host reaction. For example, while 
Simonsen's  "factor of immunization"  concept has  stressed  that  preimmuni- 
zation fails to increase significantly the number of cells responsive across strong 
H-2 barriers  (16,  cf. also  15),  our own earlier in vitro studies had indicated 
that  preimmunization  increased  both  the  ability  of  cells  to  induce  spleno- 
megaly across an intervening millipore filter (2) and that it reduced the radia- 
tion sensitivity of cells competent to cause a  graft-vs.-host reaction (7). The 
experiments we now report indicate that in direct confirmation of in vivo studies 
we cannot detect an effect of preimmunization under normal conditions, yet 
after irradiation the effect of that preimmunization is readily apparent. 
We had considered the possibility that preimmunization increased the radio- 
resistance  and  immunocompetence of cells  responding  to  non-H-2  antigens, 
since  in  that  case  one would  expect a  factor of immunization  considerably 
greater than  1. However, since we obtained essentially identical results in a 
congenic system differing only at the H-2 complex this explanation is inade- 
quate.  It will be interesting to determine whethe.r preimmunization changes 
the effector cell population in a  qualitative way or whether, perhaps, preim- 
munization leads to the production of a residual memory cell population that 
can lead to restitution following irradiation. 
To assess the ability of the in vitro system to detect differences not involving 
the  1t-2  locus  we  selected  a  strain  combination  (BALB/C  and  DBA/2)  in 
which  a  discordance between  in  vitro  and  in vivo assays  had  already been 
described  (18)  While  this  particular  strain  combination  was  known  not  to 
cause splenomegaly in vivo, Festenstein had observed that stimulation in mixed 
leukocyte culture  was  as  strong  between  BALB/C  and  DBA  as  it  was  be- 
tween  BALB/C  and  the  11-2 incompatible  strain  CBA.  When  we  assayed 
DBA and BALB/C cells using the technique (14) of one-way mixed leukocyte 
culture, we found that BALB/C cells were stimulated  as well by DBA/2  as 
by CBA cells,  and even DBA/2  cells responded almost as strongly (80%)  to 
BALB/C  as to  CBA cells.  At the same time we too were unable  to show a 
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on the  other hand,  while both DBA and BALB/C cells were able to induce 
splenomegaly, the response was consistently weak. Since most standard tests 
of transplantation would have predicted such a weak reaction, and since recently 
it has been shown that  this strain  combination causes a  weak graft-vs.-host 
reaction as measured by local lymph node enlargement (19), it would appear 
that our in vitro assay of the graft-vs.-host reaction may be more representative 
of  the  strength  of  immunological  incompatibility  than  either  the  in  vivo 
splenomegaly assay or the in vitro mixed leukocyte system. 
As part of the present study we initiated an extensive series of experiments 
(436 cultures) in which we attempted to study synergistic interactions between 
inguinal lymph node cells and normal thymus, regenerating thymus, or thymus- 
derived spleen cells. By use of a variety of cell concentrations and labeling times 
we felt that the in vitro system would provide an ideal opportunity for char- 
acterizing the nature of synergism in the graft-vs.-host reaction. Nevertheless, 
we were unsuccessful in demonstrating any significant degree of cell interactions 
in our experiments. However, our test system utilized C57BL/6 effector cells 
tested against BDF! neonatal spleen explants, and when we attempted to show 
synergism in vivo we were unable to do so in this strain combination. Since the 
studies after which we modelled our experiments were carried out with BALB/C 
effector cells reacting against BALB/C  )<  C57BL/6 hybrids, it now becomes 
of paramount importance to repeat our experiments using the strain combina- 
tions for which synergism had been previously reported (17). 
The described in vitro assay of the graft-vs.-host reaction certainly requires 
more effort and care than is needed for the in vivo assessment; for this reason 
some of the advantages of the in vitro system should be emphasized. The system 
is highly reproducible, internally controlled, and readily expressed in quantita- 
tive terms. Attrition due to maternal neglect or host variability is eliminated. 
A relatively short period of time (2-3 days) is required before a positive reaction 
can be observed. There is a high degree of sensitivity both as seen in combina- 
tions not involving the H-2 locus and as evidenced by the detection of responses 
given by low numbers of cells. Multiple cultures can be set up; there are inherent 
controls for viability; cells can be added or removed at will; and the system 
lends itself to the use of immunosuppressants, antisera, and the use of sequential 
labeling procedures. Taken together these features would seem to suggest that 
the in vitro graft-vs.-host reaction may be particularly useful for studies  of 
differentiation of immunocompetent cells,  for analysis of specific cellular sub- 
populations,  and for a  critical attack on the questions of cell interactions in 
cellular immunity. 
SUMMARY 
The primary purpose of this study has been to validate the in vitro graft-vs.- 
host  reaction as  an  experimental system.  Time-dose studies  have been pre- 
sented  for  cells  obtained  from  spleen,  thymus,  cortisone-treated  thymus, ROBERT  AUERBACH  AND  M.  R.  SHALAB¥  1519 
inguinal lymph node, mesenteric lymph node, thoracic duct, and bone marrow 
cells. Both the degree of splenomegaly and the onset of spleen enlargement were 
found to be dependent on the number and source of cells tested. 
The effect of several immunosuppressive agents was examined. Amantadine 
was found  to  suppress  completely the  graft-vs.-host reaction  in  vitro  when 
present  at  a  concentration  of  75  ug/ml.  Pretreatment  of effector cells  with 
mitomycin C prevented their subsequent ability to cause a graft-vs.-host reac- 
tion. The effect of X  irradiation on immunocompetence of spleen cells in vitro 
paralleled the known effect of irradiation on in vivo immunocompetence. 
Preimmunization  did not  increase the number or effectiveness of immuno- 
competent  cells  when  measured  under  standard  in  vitro  conditions.  Preim- 
munization did,  however, permit persistence of immunocompetence after im- 
munosuppressive doses of X  irradiation. Studies using congenic lines, moreover, 
indicated  that  the  preimmunization  effect  could  be  demonstrated  in  strain 
combinations differing only in factors determined by the 11-2 complex of genes. 
A weak graft-vs.-host reaction could be detected in strain combinations not 
involving differences at the 11-2 locus. The potential of the in vitro graft-vs.- 
host reaction as a highly reproducible, quantifiable, internally controlled, and 
experimentally accessible  system for study  of  such  critical  problems as  cell 
differentiation and cell interactions is discussed. 
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